Welcome to our micro-module webcast on the challenges of managing chronic kidney disease (CKD) and diabetes. After diagnosis, slowing CKD progression in type 2 diabetes (T2D) continues to pose a major challenge. Although new therapies, such as sodium-glucose cotransporter-2 (SGLT-2) inhibitors, have emerged, residual morbidity and mortality persist. Additional strategies are required to slow kidney disease progression, especially targeting inflammation and fibrosis. This educational activity aims to bridge the gaps in recognizing and treating CKD in T2D patients among healthcare professionals, particularly primary care clinicians and others on the front lines. This micromodule webcast is designed to enhance early screening, diagnosis, and treatment of this condition.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://cme.tarsusmedicaleducation.com/cardiometabolic-health-congress-cmhc-/content/optimizing-recognition-and-treatment-chronic-kidney-disease-patients-type-2-diabetes_1739
- Start Date: 2024-08-30 05:00:00
- End Date: 2024-08-30 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
Nursing: 1.25 hours
Pharmacy: 1.25 hours - Commercial Support: Source: Bayer (Any division) - Amount: 110451.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all